ZHOU Tong, YANG Chuan-liang, LIN Yang. A cost-benefit analysis of paclitaxel/5-fluorouracil/cisplatin compared with oxaliplatin/5-fluorouracil/leucovorin in treatment of advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2006, (11): 28-29. DOI: 10.3969/j.issn.1672-2353.2006.11.009
|
Citation:
|
ZHOU Tong, YANG Chuan-liang, LIN Yang. A cost-benefit analysis of paclitaxel/5-fluorouracil/cisplatin compared with oxaliplatin/5-fluorouracil/leucovorin in treatment of advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2006, (11): 28-29. DOI: 10.3969/j.issn.1672-2353.2006.11.009
|
ZHOU Tong, YANG Chuan-liang, LIN Yang. A cost-benefit analysis of paclitaxel/5-fluorouracil/cisplatin compared with oxaliplatin/5-fluorouracil/leucovorin in treatment of advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2006, (11): 28-29. DOI: 10.3969/j.issn.1672-2353.2006.11.009
|
Citation:
|
ZHOU Tong, YANG Chuan-liang, LIN Yang. A cost-benefit analysis of paclitaxel/5-fluorouracil/cisplatin compared with oxaliplatin/5-fluorouracil/leucovorin in treatment of advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2006, (11): 28-29. DOI: 10.3969/j.issn.1672-2353.2006.11.009
|
DownLoad: